PT  - JOURNAL ARTICLE
AU  - Fishman, M.
AU  - Dutcher, J. P.
AU  - Clark, J. I.
AU  - Alva, A.
AU  - Miletello, G. P.
AU  - Curti, B.
AU  - Agarwal, Neeraj
AU  - Hauke, R.
AU  - Mahoney, K. M.
AU  - Moon, H.
AU  - Treisman, J.
AU  - Tykodi, S. S.
AU  - Daniels, G.
AU  - Morse, M. A.
AU  - Wong, M. K. K.
AU  - Kaufman, H.
AU  - Gregory, N.
AU  - McDermott, D. F.
TI  - Overall survival by clinical risk category for high dose interleukin-2 (HD IL-2) treated patients with metastatic renal cell cancer (mRCC): data from the PROCLAIM<sup>SM</sup> registry
AID  - 10.1186/s40425-019-0567-3
DP  - 2019 Dec 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - 84
VI  - 7
IP  - 1
4099  - http://jitc.bmj.com/content/7/1/84.short
4100  - http://jitc.bmj.com/content/7/1/84.full
SO  - J Immunother Cancer2019 Dec 01; 7
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.